The Murphy & McGonigle International Advisory team provides strategic and general business advice to clients on international business expansions, operations and global transactions, specifically in the areas of financial services, biotech, energy and health care. From managing M&A transactions and negotiating a broad range of commercial agreements in Asia-Pacific, Canada, Latin America, and the European Union to serving as the Independent Advisor for a Swiss bank to our work with international entities on FCPA and anti-bribery policies and procedures, our team helps our international clients face unique and challenging issues.
We provide our clients with up-to-date information in order to anticipate and react to impending regulatory changes. But beyond that, our attorneys’ strong relations with government and business leaders help us keep our clients informed with regard to doing business globally. Our team offers guidance on a wide range of matters – from acting as a sounding board to providing a plan of action to working hand-in-hand with our clients.
Our clients benefit from our experience and understanding of business goals and legal issues domestically and abroad.
Our attorneys are fluent in Spanish, Vietnamese, Mandarin Chinese, German and French.
A recent Deloitte survey indicates the 2018 trend of increased IPOs is likely to continue, with almost 80% of respondents expecting an increase in the number of deals they close in 2019. Corruption hotspots will remain little changed in 2019. Likewise, significant enforcement efforts can be expected to continue. Two of the largest anti-corruption settlements in history were brought in 2018: Petrobras ($1.78 billion) and Société Générale ($585 million). Notably, each investigation was conducted by the U.S. government in coordination with foreign national governments. The increase in involvement of foreign enforcement agencies will certainly continue.